STAT3 and breast carcinoma: In continuation of our research on the effects of inhibition of JAK2/STAT3 signaling pathway in breast cancer tumor cells [30, 31], the aim of this study was to investigate whether CPT, naringenin, and their combination could modify immune response, immune cell proliferation, and cytokine production.